Histone cluster 1 H2BD inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the Histone cluster 1 H2BD protein, a variant of the histone H2B family that plays a crucial role in the organization and regulation of chromatin structure. Histones are core components of nucleosomes, around which DNA is wrapped, and they are essential for the compaction of DNA within the nucleus and the regulation of gene expression. The H2BD variant, like other histones, is involved in the dynamic processes of chromatin remodeling, which influence accessibility to the genetic material for transcription, replication, and repair. Inhibitors of Histone cluster 1 H2BD are typically small molecules that interact with specific regions of the protein, such as the histone fold domain or sites involved in post-translational modifications, which are crucial for its interaction with DNA and other histone proteins.
The development of Histone cluster 1 H2BD inhibitors involves a deep understanding of the structural biology of histones and their interactions within the nucleosome. Researchers employ a variety of techniques, including high-throughput screening, to identify potential inhibitory compounds that can bind to H2BD and disrupt its function. These compounds are then optimized through structure-activity relationship (SAR) studies to enhance their specificity, binding affinity, and stability. The chemical structures of these inhibitors are often diverse, with specific functional groups that facilitate strong interactions with the protein, such as hydrogen bonding, hydrophobic interactions, and van der Waals forces. Advanced techniques like X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are utilized to visualize these interactions at the atomic level, providing critical insights that guide the refinement of the inhibitors. Achieving high selectivity is a key objective in the design of Histone cluster 1 H2BD inhibitors, ensuring that these compounds precisely target H2BD without interfering with other histone variants or components of the chromatin. This specificity is crucial for enabling researchers to modulate chromatin dynamics and study the role of H2BD in gene regulation and chromatin architecture, providing valuable insights into the fundamental processes governing cellular function and gene expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
A natural phenol that has been shown to inhibit histone acetyltransferases, potentially affecting histone acetylation and function. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $136.00 $492.00 | 13 | |
A HAT inhibitor that can affect histone acetylation. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $260.00 $925.00 | 5 | |
A competitive HAT inhibitor, influencing histone acetylation. | ||||||
I-CBP112 | 1640282-31-0 | sc-507494 | 25 mg | $400.00 | ||
Designed to inhibit the bromodomains of CBP/p300, affecting histone acetylation. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A thienotriazolodiazepine that inhibits bromodomains in histones, influencing gene regulation. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $210.00 $242.00 $1434.00 | 2 | |
A benzamide HDAC inhibitor that can influence histone deacetylation. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $214.00 $622.00 | 1 | |
A cyclic peptide that acts as an HDAC inhibitor, influencing histone acetylation. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $153.00 $561.00 | ||
A hydroxamic acid that acts as an HDAC inhibitor, affecting histone acetylation. | ||||||